Research journal/Melatonin Research

Melatonin and Circadian Rhythm: How the Biology Actually Works

  • August 8, 2026
  • 3 min read
  • Sierra Life Sciences

Melatonin and Circadian Rhythm: How the Biology Actually Works

Melatonin is a circadian signal, not a sedative. Understanding the distinction — and how the circadian system actually works — changes how you think about melatonin supplementation.

Melatonin is commonly described as a “sleep hormone.” This description is technically imprecise in ways that matter.* Melatonin is more accurately a darkness signal — a circadian timing cue — rather than a direct sleep inducer.* The distinction is not trivial: it changes how supplemental melatonin should be understood and how it works physiologically.* Informational only — not medical advice.*

The Suprachiasmatic Nucleus and Circadian Timing

The master circadian clock in humans resides in the suprachiasmatic nucleus (SCN) — a paired structure of approximately 20,000 neurons in the anterior hypothalamus.* The SCN generates an intrinsic ~24-hour oscillation driven by interlocking transcription-translation feedback loops involving clock genes (CLOCK, BMAL1, PER1-3, CRY1-2).* This endogenous rhythm is called a “free-running” rhythm — it continues in the absence of external time cues, though it typically runs slightly longer than 24 hours in humans.*

The SCN must be synchronized to the environmental 24-hour light-dark cycle each day — a process called “entrainment.” The primary entrainment signal is light, which is detected by intrinsically photosensitive retinal ganglion cells (ipRGCs) containing melanopsin and transmitted to the SCN via the retinohypothalamic tract.* Melatonin is the output signal through which the SCN communicates the time of day to peripheral tissues throughout the body.*

How Melatonin Is Produced and Regulated

The SCN projects to the paraventricular nucleus, which connects through a multisynaptic pathway to the superior cervical ganglia, which in turn innervate the pineal gland.* Light exposure suppresses this pathway and halts melatonin production; darkness activates it.* The result is a predictable nocturnal rise in melatonin — typically beginning 2–3 hours before habitual sleep onset (the “dim light melatonin onset” or DLMO) and peaking in the early-to-mid sleep period.*

Melatonin does not cause sleep directly — it signals darkness to SCN-driven processes that prepare the body for sleep.* Body temperature drops, heart rate slows, and cortisol declines — all driven by the circadian clock responding to melatonin’s darkness signal.* Sleep itself is regulated by a separate process — “sleep pressure” driven by accumulation of adenosine in the brain during wakefulness.* Melatonin and sleep pressure interact, but they are distinct systems.*

What This Means for Supplemental Melatonin

Understanding melatonin as a circadian signal — not a sedative — explains several features of its supplemental use:*

  • Timing matters more than dose for circadian effects. Melatonin’s phase-shifting effects on the circadian clock are highly dependent on when it’s taken relative to the current circadian phase.* The same dose taken at different times of day produces different — sometimes opposite — effects on circadian timing.*
  • Low doses are often cited for circadian applications. For circadian phase-shifting (jet lag, shift work), research has often examined doses in the 0.5–3mg range — much lower than doses studied for antioxidant properties.* Higher doses can be more sedating without necessarily being more effective for pure circadian timing.*
  • Light exposure interacts with supplemental melatonin. Light suppresses melatonin production regardless of supplementation — strong light exposure during or after melatonin supplementation partially counteracts its effects.*

Melatonin Receptor Biology

Melatonin acts through two high-affinity G protein-coupled receptors — MT1 and MT2 — expressed throughout the brain and peripheral tissues.* MT1 is primarily associated with circadian phase-shifting and direct sleep-promoting effects.* MT2 is primarily associated with circadian phase-shifting.* Both are expressed in the SCN.* Ramelteon, a prescription sleep medication, is a selective MT1/MT2 agonist — it works by mimicking melatonin at these receptors.* Supplemental melatonin acts at both receptors and additionally at a binding site (MT3, identified as quinone reductase 2) involved in antioxidant signalling.*

See our full range: Pure Bulk Powder | 10mg | 60mg | 120mg | Melatonin Antioxidant Research

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Informational only — research citations are for educational purposes. Not medical advice.

Share:

Facebook
Twitter
Pinterest
LinkedIn

Table of Contents

On Key

Related Posts

From the people who make it

Formulated, made and tested in Santa Rosa, California.

Short ingredient lists, exact doses and third-party testing — straight from our cGMP facility.